Crypto Updates

Cracking The Code: Understanding Analyst Reviews For ACADIA Pharmaceuticals

Veteran Trader Peter Brandt Asks Macro Guru If Bitcoin Bull Has Finally Awoken From Deep Slumber

Latest Ratings for ACAD

Date Firm Action From To
Mar 2022 Cantor Fitzgerald Maintains Overweight
Mar 2022 Goldman Sachs Maintains Neutral
Mar 2022 Mizuho Maintains Neutral

View More Analyst Ratings for ACAD

View the Latest Analyst Ratings

Read the full story on Benzinga.com

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Click Here to Read the Full Original Article at Cryptocurrencies Feed…